A junior research group under the Translational Neurogenetics Section has been formed to spearhead genetic and genomic approaches including genome sequencing, deep mito-sequencing, RNA sequencing and epigenetics to identify highly penetrant mutations, risk factors and disease modifying genetic variants in Parkinson’s disease. One focus of this research group will be on genetic modifiers of reduced penetrance, which will strengthen the Research Unit.